Salarius Pharmaceuticals

+$0.0187 (+8.45%) Today
+$0.009 (+3.75%) As of 9:24 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.

About SLRX

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.

CEO
David J. Arthur
Employees
16
Headquarters
Houston, Texas
Founded
2014

SLRX Key Statistics

Market cap
13.55M
Price-Earnings ratio
—
Dividend yield
—
Average volume
909.97K
High today
$0.2594
Low today
$0.2151
Open price
$0.23
Volume
1.91M
52 Week high
$1.20
52 Week low
$0.1599

SLRX Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure